Guardant Health Stock Performance

GH Stock  USD 114.04  3.56  3.22%   
On a scale of 0 to 100, Guardant Health holds a performance score of 8. The company retains a Market Volatility (i.e., Beta) of 0.29, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Guardant Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Guardant Health is expected to be smaller as well. Please check Guardant Health's semi deviation, sortino ratio, semi variance, as well as the relationship between the standard deviation and value at risk , to make a quick decision on whether Guardant Health's current trending patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Guardant Health are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady technical indicators, Guardant Health demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
3.22
Five Day Return
(0.71)
Year To Date Return
12.09
Ten Year Return
254.16
All Time Return
254.16
1
Disposition of 155 shares by Krognes Steve E. of Guardant Health subject to Rule 16b-3
11/28/2025
2
Disposition of 2000 shares by Kumud Kalia of Guardant Health at 104.6021 subject to Rule 16b-3
12/10/2025
3
Chevron To Rally Around 37 Here Are 10 Top Analyst Forecasts For Friday
12/12/2025
4
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/29/2025
5
Disposition of 23997 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3
12/31/2025
6
Guardant Healths Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families
01/08/2026
7
Disposition of 17379 shares by Terilyn Monroe of Guardant Health subject to Rule 16b-3
01/15/2026
8
Acquisition by Hidalgo Medina Manuel of 232 shares of Guardant Health subject to Rule 16b-3
01/16/2026
9
Acquisition by Mignone Roberto of 264 shares of Guardant Health subject to Rule 16b-3
01/21/2026
10
Wall Street Has a Positive Opinion on Guardant Health
01/23/2026
11
Y Intercept Hong Kong Ltd Has 4.77 Million Holdings in Guardant Health, Inc. GH - MarketBeat
01/26/2026
12
Should You Buy Guardant Health Before Feb. 19
01/30/2026
Begin Period Cash Flow1.1 B
Total Cashflows From Investing Activities-261.3 M

Guardant Health Relative Risk vs. Return Landscape

If you would invest  9,814  in Guardant Health on November 4, 2025 and sell it today you would earn a total of  1,590  from holding Guardant Health or generate 16.2% return on investment over 90 days. Guardant Health is generating 0.2769% of daily returns and assumes 2.5065% volatility on return distribution over the 90 days horizon. Put differently, 22% of stocks are less risky than Guardant on the basis of their historical return distribution, and some 95% of all equities are expected to be superior in generating returns on investments over the next 90 days.
  Expected Return   
       Risk  
Allowing for the 90-day total investment horizon Guardant Health is expected to generate 3.37 times more return on investment than the market. However, the company is 3.37 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Guardant Health Target Price Odds to finish over Current Price

The tendency of Guardant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 114.04 90 days 114.04 
about 10.99
Based on a normal probability distribution, the odds of Guardant Health to move above the current price in 90 days from now is about 10.99 (This Guardant Health probability density function shows the probability of Guardant Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon Guardant Health has a beta of 0.29. This usually indicates as returns on the market go up, Guardant Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Guardant Health will be expected to be much smaller as well. Additionally Guardant Health has an alpha of 0.7835, implying that it can generate a 0.78 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Guardant Health Price Density   
       Price  

Predictive Modules for Guardant Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Guardant Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
111.55114.04116.53
Details
Intrinsic
Valuation
LowRealHigh
95.5898.07125.44
Details
24 Analysts
Consensus
LowTargetHigh
113.97125.24139.01
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.58-0.44-0.26
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Guardant Health. Your research has to be compared to or analyzed against Guardant Health's peers to derive any actionable benefits. When done correctly, Guardant Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Guardant Health.

Guardant Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Guardant Health is not an exception. The market had few large corrections towards the Guardant Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Guardant Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Guardant Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.78
β
Beta against Dow Jones0.29
σ
Overall volatility
9.39
Ir
Information ratio 0.18

Guardant Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Guardant Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Guardant Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company generated the yearly revenue of 739.02 M. Annual Net Loss to common stockholders was (436.37 M) with gross profit of 575.46 M.
Guardant Health reports about 853.69 M in cash with (239.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Over 97.0% of the company shares are owned by institutional investors
Latest headline from insidermonkey.com: Heres What Lifted Globus Medical in Q4

Guardant Health Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Guardant Stock often depends not only on the future outlook of the current and potential Guardant Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardant Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding122.7 M
Cash And Short Term Investments840 M

Guardant Health Fundamentals Growth

Guardant Stock prices reflect investors' perceptions of the future prospects and financial health of Guardant Health, and Guardant Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardant Stock performance.

About Guardant Health Performance

By evaluating Guardant Health's fundamental ratios, stakeholders can gain valuable insights into Guardant Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Guardant Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Guardant Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 80.58  68.94 
Return On Tangible Assets(0.34)(0.36)
Return On Capital Employed(0.40)(0.43)
Return On Assets(0.34)(0.35)
Return On Equity 3.59  3.77 

Things to note about Guardant Health performance evaluation

Checking the ongoing alerts about Guardant Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guardant Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company generated the yearly revenue of 739.02 M. Annual Net Loss to common stockholders was (436.37 M) with gross profit of 575.46 M.
Guardant Health reports about 853.69 M in cash with (239.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Over 97.0% of the company shares are owned by institutional investors
Latest headline from insidermonkey.com: Heres What Lifted Globus Medical in Q4
Evaluating Guardant Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Guardant Health's stock performance include:
  • Analyzing Guardant Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardant Health's stock is overvalued or undervalued compared to its peers.
  • Examining Guardant Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Guardant Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardant Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Guardant Health's stock. These opinions can provide insight into Guardant Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Guardant Health's stock performance is not an exact science, and many factors can impact Guardant Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk